Atlas Trials

Gammopathy, Monoclonal

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gammopathy, Monoclonal

RecordFirmDate
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma (NCT05573802)Hellenic Society of Hematology2023-07-14
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory (NCT05581875)Hellenic Society of Hematology2022-10-20
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible (NCT05280275)Hellenic Society of Hematology2022-04-13
Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik) (NCT06559579)University Hospital, Brest2021-10-01
Rifaximin in Patients With Monoclonal Gammopathy (NCT03820817)Emory University2019-05-15

Track Gammopathy, Monoclonal automatically

Every clearance here is in the API, with alerts when new ones post.